1. Matsell DG, Bennett T, Goodyer P, Goodyer C, Han VK. The pathogenesis of multicystic dysplastic kidney disease: insights from the study of fetal kidneys. Lab Invest. 1996; 74:883–893.
2. Weinstein A, Goodman TR, Iragorri S. Simple multicystic dysplastic kidney disease: end points for subspecialty follow-up. Pediatr Nephrol. 2008; 23:111–116.
3. Cambio AJ, Evans CP. Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH). Ther Clin Risk Manag. 2007; 3:181–196.
4. Barrett DM, Wineland RE. Renal cell carcinoma in multicystic dysplastic kidney. Urology. 1980; 15:152–154.
5. Birken G, King D, Vane D, Lloyd T. Renal cell carcinoma arising in a multicystic dysplastic kidney. J Pediatr Surg. 1985; 20:619–621.
6. Rackley RR, Angermeier KW, Levin H, Pontes JE, Kay R. Renal cell carcinoma arising in a regressed multicystic dysplastic kidney. J Urol. 1994; 152(5 Pt 1):1543–1545.
7. Cambio AJ, Evans CP, Kurzrock EA. Non-surgical management of multicystic dysplastic kidney. BJU Int. 2008; 101:804–808.
8. Prasad SR, Humphrey PA, Catena JR, Narra VR, Srigley JR, Cortez AD, et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics. 2006; 26:1795–1806. discussion 1806-1810